Clinical Trials
All Clinical Trials - Page 26 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05054361N/ARecruiting
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Ll-37
- NCT05184374N/AUnknown
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Gonadorelin
- NCT06020456N/ACompleted
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
Desmopressin
- NCT05194124Phase 3Completed
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Setmelanotide
- NCT04919226Phase 3Active Not Recruiting
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
Octreotide
- NCT05153772Phase 2Active Not Recruiting
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
Octreotide
- NCT04989946Phase 1/Phase 2Active Not Recruiting
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Gonadorelin
- NCT05857085Phase 4Completed
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
Semaglutide
- NCT04522622Phase 4Recruiting
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide
- NCT05093634Phase 3Completed
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Setmelanotide
- NCT05050084Phase 3Active Not Recruiting
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Gonadorelin
- NCT05153590N/ACompleted
A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
Liraglutide
- NCT07028320Phase 3Completed
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Teriparatide
- NCT05013229Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
Semaglutide
- NCT05111912Phase 2Completed
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Liraglutide
- NCT04963231Phase 2Completed
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Setmelanotide
- NCT05760222N/AUnknown
Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients
Gonadorelin
- NCT05132088Phase 3Completed
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Semaglutide
- NCT05086445Phase 1Completed
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Orforglipron
- NCT04243629N/AUnknown
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
Pramlintide
- NCT05110794Phase 1Completed
A Multiple-Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05059236Phase 2Completed
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
Gonadorelin
- NCT05166668N/ACompleted
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
Gonadorelin
- NCT05171751N/ACompleted
Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia
Octreotide
- NCT05071417Phase 3Unknown
Effect Of Semaglutide In Coronary Atheroma Plaque
Semaglutide
- NCT05112692N/AUnknown
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Gonadorelin
- NCT06182891N/ACompleted
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
Dulaglutide
- NCT04958109Phase 1Completed
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Kisspeptin
- NCT04983095N/ARecruiting
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
Gonadorelin
- NCT05050942Phase 3Active Not Recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Octreotide
- NCT05159752Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Afamelanotide
- NCT05096598Phase 1Completed
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
Petrelintide
- NCT04199728Phase 1/Phase 2Completed
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Liraglutide
- NCT04455750Phase 3Active Not Recruiting
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
Gonadorelin
- NCT04931342Phase 2Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Gonadorelin
- NCT04466345Phase 2Completed
Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
Semaglutide
- NCT05064735Phase 3Completed
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Semaglutide
- NCT05034783EARLY_Phase 1Unknown
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Exenatide
- NCT05051579Phase 2Completed
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Orforglipron
- NCT05048901Phase 1/Phase 2Recruiting
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Lanreotide
- NCT05051566Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05606471Phase 4Unknown
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
Semaglutide
- NCT05048719Phase 2Completed
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT04897802Phase 4Completed
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Exenatide
- NCT05056246Phase 1Completed
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
Maridebart-Cafraglutide
- NCT05040971Phase 3Completed
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
Semaglutide
- NCT04965506Phase 2Completed
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
Dulaglutide
- NCT05024032Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Tirzepatide
- NCT04892199Phase 4Unknown
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Semaglutide
- NCT05040087N/AActive Not Recruiting
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
Semaglutide